TMEM161B and esophageal squamous cell carcinoma: A recent study showed that overexpression of TMEM161B-AS1 inhibited proliferation, invasion, and glycolysis, as well as glucose uptake and lactic acid generation in ESCC cells (Shi et al., 2021).